2019: A Banner Year for Tuberculosis Research.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32043109.
- Also identified by DOI 10.1093/infdis/jiaa051 and PMC identifier 7653083.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This article outlines the significant scientific progress reported in 2019 that has led to the development of new drugs and therapeutic regimens, vaccine candidates, and diagnostics for the prevention and treatment of tuberculosis. In 2020, it will be important to build on this momentum and continue to advance basic and clinical research to develop improved tools and interventions, simultaneously optimizing their implementation in national control programs. To successfully achieve the goal to end tuberculosis within a generation, a concerted, collective, and collaborative effort is required, involving government, academia, industry and civil society at all levels.
Medical subject headings
- Tuberculosis